Kyverna Therapeutics, Inc.
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KYTX and other ETFs, options, and stocks.About KYTX
Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.
KYTX Key Statistics
Stock Snapshot
As of today, Kyverna Therapeutics, Inc.(KYTX) shares are valued at $9.49. The company's market cap stands at 558.39M, with a P/E ratio of -2.52.
As of 2026-05-06, Kyverna Therapeutics, Inc.(KYTX) stock has fluctuated between $9.00 and $9.38. The current price stands at $9.49, placing the stock +5.5% above today's low and +1.2% off the high.
Kyverna Therapeutics, Inc.(KYTX) shares are trading with a volume of 748.33K, against a daily average of 1.56M.
In the last year, Kyverna Therapeutics, Inc.(KYTX) shares hit a 52-week high of $13.67 and a 52-week low of $1.92.
In the last year, Kyverna Therapeutics, Inc.(KYTX) shares hit a 52-week high of $13.67 and a 52-week low of $1.92.
Analyst ratings
100%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.